DSD-T308

Congenital adrenal hyperplasia (CAH) · DSD-T308

DSD-T308 · Sex chromosome DSD · 2023 · Automated translation

Phenotypes HPO:0000135, HPO:0000771, Hypogonadism (HP:0000135), Gynecomastia (HP:0000771)

Non-classic 21-hydroxylase deficiency (46,XX) with ectopic prostatic tissue in the cervix.

Case fields and evidence

Category

Congenital adrenal hyperplasia (CAH)

Sex

Female (female sex of rearing, 46,XX)

Phenotypes

Hypogonadism (HP:0000135); Gynecomastia (HP:0000771)

Diagnosis

Non-classic 21-hydroxylase deficiency (46,XX) with ectopic prostatic tissue in the cervix.

Follow-up

Not reported in the original text

General phenotype

Female phenotype with mild virilization (hirsutism score not described in the original text).

Imaging

Not reported in the original text

Laboratory findings

Hyperandrogenism (specific values are in Table 1 of the original article and not listed in the main text); pre-conization PSA <0.03 ng/mL (below the male reference value).

Management

Oral hydrocortisone 20 mg/day from age 10 to 14 to suppress adrenal androgen synthesis, but hormonal control was inadequate; the medication was discontinued at the patient's request after completion of growth; prednisolone 2 mg/day was added at age 28 for fertility assistance; after conization in 2022, switched to modified-release hydrocortisone 10 mg/day combined with an anti-androgenic oral contraceptive

Pathology

Cervical tissue showed ectopic prostatic tissue, positive for PSA and NKX3.1.

Evidence level

See source

Clinical history

See source

Karyotype

See source

Cite this resource

DSD Research Library | Congenital adrenal hyperplasia (CAH) · DSD-T308 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T308?version=v1.4.0